ESG

A major update to the Kosmos platform brings cart-grade OB/GYN and vascular tools to a portable device, reshaping diagnostics from the ER to rural clinics.

In a landmark $9.9 billion all-cash deal, Danaher will acquire Masimo, aiming to dominate the patient monitoring market from hospital to home.

Camping app The Dyrt is giving away $500,000 in PRO subscriptions. A look at the high-stakes strategy to capture the booming RV market.

A new collaborative is launching major health services, from maternal care to mental health, to address deep-seated disparities on Chicago's Far Southside.

With a new rotator cuff device and enhanced meniscal repair system, Arcuro Medical is challenging orthopedic giants with its innovative all-suture technology.

An Innventure company proves its technology can turn real-world plastic trash into valuable chemicals, but can it navigate the path to commercialization?

As Revvity execs prepare for key conferences, investors will watch for clues on AI strategy, growth guidance, and margin recovery after a mixed 2025.

An independent board again backs the safety of BriaCell's metastatic breast cancer therapy in a pivotal Phase 3 trial, boosting hope for a new treatment.

A new five-year deal will leverage patient-derived stem cells and AI to revolutionize the hunt for Alzheimer's cures, aiming to bridge a critical gap.

A new partnership aims to manufacture a life-saving gene therapy for NKH, a devastating rare disorder, driven by a family's relentless advocacy.

After a $6M cash infusion and leadership change, the diagnostics firm is selling its flagship product to chase a high-risk, high-reward U.S. market.

With a new regulatory chief, Ray Therapeutics accelerates its mission to bring its goggle-free optogenetic therapies for blindness through clinical trials.

An Indiana firm's implantable pump gains key FDA status, promising a future with less mental burden for Type 1 Diabetes patients. But the road is long.

Amidst a volatile stock history, GT Biopharma aims to secure vital funding for its innovative NK cell therapy pipeline at a key Toronto conference.

Spot's milestone highlights a major trend: as vet costs rise, pet insurance is becoming a crucial financial tool for American families and their pets.

With 23,000 metres of drilling, Copper Giant aims to unlock one of the world's largest undeveloped copper caches, vital for the energy transition.

A fatal crash and a spike in deaths have prompted a stark warning: the mix of jets, helicopters, and drones in our airspace is a growing global threat.

Ascend Elements' award to TDK Ventures reveals a new VC model, where hands-on partnership is key to building a secure, circular battery supply chain.

Fresh off a $1.1B IPO and a #1 GreenTech ranking, BETA Technologies faces investors to prove its electric aviation vision is commercially viable.

With a key depression drug nearing Phase 3 and more data imminent, AtaiBeckley is set to make its case to Wall Street at three major March conferences.